C-19 shot studies used by HHS conducted in China

Latest Polls (view all)

Under the cover of Covid, and now in the shadow of the infamous Election Irregularities of that fated 2020 presidential election, with current emerging alleged election fraud in Nevada and Pennsylvania inconveniently slipping into the public discourse, there is proved a colluded ongoing Election Interference in the nomination of the Republican candidate, the likes of which has never occurred in our Constitutional Republic's history, albeit, the question remains: Do you support the plain-sight Election Interference of the Democratic Socialist party, employing its minions in their Propagandistic Media, and their Two Tiered Justice System?

98.85% No, I do not support Election Interference; I am a patriot unto our Constitution.

1.15% Yes, I do support Election Interference; the alternative, Donald Trump, to this mentally diminished president is far worse.

0% "What, me worry" if elections are rigged?

Click Here to Vote
87 Vote(s)

View all Polls

C-19 shot studies used by HHS conducted in China

Published: Tuesday, September 27th, 2022 @ 11:38 am
By: Countrygirl1411 ( More Entries )

Login to Send a Private Message to Countrygirl1411

Judicial Watch announced today that it received 115 pages of records from the Department of Health and Human Services (HHS) revealing previously redacted locations of COVID-19 vaccine testing facilities in Shanghai, China. The Food and Drug Administration (FDA) had claimed the name and location of the testing facilities were protected by the confidential commercial information exemption of the Freedom of Information Act (FOIA).

The newly unredacted documents reveal the following Pfizer/BioNTech COVID-19 vaccine studies’ locations:

A document with the filename, “ s_r_IND 19736 0 105 2.6.5 pharmkintabulated-summary” identifies all in vitro metabolic stability studies of ALC-0315 and ALC-0159 (synthetic lipids in the vaccines) were conducted at Medicilon Preclinical Research LLC, a testing facility located in Shanghai, China. Studies within this record indicate work was done in August 2020.
A document with the filename, “s_r_IND 19736-0-253 Section 2.6.5 pharmkintabulated-summary” identifies that all in vitro metabolic stability studies of ALC-0315 and ALC-0159 were conducted at Medicilon Preclinical Research LLC, a testing facility located in Shanghai, China. Studies within this record indicate work was done in August 2020.

Additionally, Study 18350 was conducted at a Charles River testing facility in Tranent, UK

A document with the filename, “s_pharmkin-tabulated-summary.pdf” notes that all in vitro metabolic stability studies of ALC-0315 and ALC-0159 were conducted at Medicilon Preclinical Research LLC, a testing facility located in “Shanghai, China.” Studies within this record indicate work was done in August 2020.

The document adds that Study 18350 was conducted at a Charles River testing facility in Tranent, UK.

A document titled “FINAL REPORT” with the filename, “s_r_185350.pdf” and the logo, “Charles River” lists the TESTING FACILITY as “Charles River Laboratories Edinburgh Ltd. Elphinstone Research Centre Tranent, East Lothian EH33 2NE, UK” Studies within this record indicate the work was conducted in July 2020.

https://www.judicialwatch.org/covid-vaccine-studies-conducted-in-china/

Go Back